References

A histopathologic and morphometric differentiation of nerves in optic nerve hypoplasia and Leber hereditary optic neuropathy

10.1001/archopht.116.7.911 · ExternalCitation · doi-reference

Minocycline delays death of retinal ganglion cells in experimental glaucoma and after optic nerve transection

10.1001/archopht.124.4.520 · ExternalCitation · doi-reference

Trial end points and natural history in patients with G11778A Leber hereditary optic neuropathy : Preparation for gene therapy clinical trial

10.1001/jamaophthalmol.2013.7971 · ExternalCitation · doi-reference

Immune response and intraocular inflammation in patients with Leber hereditary optic neuropathy treated with intravitreal injection of recombinant adeno-associated virus 2 carrying the ND4 gene: a secondary analysis of a phase 1/2 clinical trial

10.1001/jamaophthalmol.2018.6902 · ExternalCitation · doi-reference

Five-year outcomes of Lenadogene Nolparvovec gene therapy in Leber hereditary optic neuropathy

10.1001/jamaophthalmol.2024.5375 · ExternalCitation · doi-reference

Mitochondrial mutations of Leber's hereditary optic neuropathy: a risk factor for multiple sclerosis

10.1007/s004150070153 · ExternalCitation · doi-reference

Evaluating the evidence for neuroprotective and axonal regenerative activities of different inflammatory cell types after optic nerve injury

10.1007/s12035-024-04679-3 · ExternalCitation · doi-reference

Safety of intravitreal gene therapy for treatment of subjects with Leber hereditary optic neuropathy due to mutations in the mitochondrial ND4 gene: The REVEAL study

10.1007/s40259-021-00468-9 · ExternalCitation · doi-reference

HLA class II genotypes in Leber's hereditary optic neuropathy

10.1016/0022-510x(94)90272-0 · ExternalCitation · doi-reference

HLA class I genotypes in Leber's hereditary optic neuropathy

10.1016/0022-510x(95)00286-b · ExternalCitation · doi-reference

Maternally transmitted histocompatibility antigen of mice: a hydrophobic peptide of a mitochondrially encoded protein

10.1016/0092-8674(90)90345-f · ExternalCitation · doi-reference

Safety of Lenadogene Nolparvovec gene therapy over 5 years in 189 patients with Leber hereditary optic neuropathy

10.1016/j.ajo.2022.11.026 · ExternalCitation · doi-reference

Apoptotic caspases suppress mtDNA-induced STING-mediated type I IFN production

10.1016/j.cell.2014.11.036 · ExternalCitation · doi-reference

HLA-DR15 molecules jointly shape an autoreactive T cell repertoire in multiple sclerosis

10.1016/j.cell.2020.09.054 · ExternalCitation · doi-reference

MTFP1 controls mitochondrial fusion to regulate inner membrane quality control and maintain mtDNA levels

10.1016/j.cell.2024.05.017 · ExternalCitation · doi-reference

Pathological mitophagy disrupts mitochondrial homeostasis in Leber's hereditary optic neuropathy

10.1016/j.celrep.2022.111124 · ExternalCitation · doi-reference

Linezolid trough concentrations correlate with mitochondrial toxicity-related adverse events in the treatment of chronic extensively drug-resistant tuberculosis

10.1016/j.ebiom.2015.09.051 · ExternalCitation · doi-reference

Safety and efficacy of ixoberogene soroparvovec in neovascular age-related macular degeneration in the United States (OPTIC): a prospective, two-year, multicentre phase 1 study

10.1016/j.eclinm.2023.102394 · ExternalCitation · doi-reference

Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis

10.1016/j.immuni.2012.01.009 · ExternalCitation · doi-reference

Oxidized DNA fragments exit mitochondria via mPTP- and VDAC-dependent channels to activate NLRP3 inflammasome and interferon signaling

10.1016/j.immuni.2022.06.007 · ExternalCitation · doi-reference

The clinical safety landscape for ocular AAV gene therapies: a systematic review and meta-analysis

10.1016/j.isci.2025.112265 · ExternalCitation · doi-reference

Leber's hereditary optic neuropathy-associated ND1 3733G>C mutation ameliorates the mitochondrial quality control and cellular homeostasis

10.1016/j.jbc.2025.110464 · ExternalCitation · doi-reference

LHON-MS - The overlaps in clinical and molecular features of both LHON and MS

10.1016/j.msard.2020.102322 · ExternalCitation · doi-reference

Minocycline, a possible neuroprotective agent in Leber's hereditary optic neuropathy (LHON): studies of cybrid cells bearing 11,778 mutation

10.1016/j.nbd.2007.07.021 · ExternalCitation · doi-reference

The iron maiden: Oligodendroglial metabolic dysfunction in multiple sclerosis and mitochondrial signaling

10.1016/j.neubiorev.2024.105788 · ExternalCitation · doi-reference

Systemic and local immune responses to intraocular AAV vector administration in non-human primates

10.1016/j.omtm.2022.01.011 · ExternalCitation · doi-reference

Cellular signaling and factors involved in Müller cell gliosis: neuroprotective and detrimental effects

10.1016/j.preteyeres.2009.07.001 · ExternalCitation · doi-reference

Mitochondrial optic neuropathies - disease mechanisms and therapeutic strategies

10.1016/j.preteyeres.2010.11.002 · ExternalCitation · doi-reference

Retinal ganglion cells: Energetics, compartmentation, axonal transport, cytoskeletons and vulnerability

10.1016/j.preteyeres.2013.07.001 · ExternalCitation · doi-reference

Immune responses to retinal gene therapy using adeno-associated viral vectors - Implications for treatment success and safety

10.1016/j.preteyeres.2020.100915 · ExternalCitation · doi-reference

AAV vector immunogenicity in humans: a long journey to successful gene transfer

10.1016/j.ymthe.2019.12.010 · ExternalCitation · doi-reference

Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial

10.1016/s0140-6736(17)31868-8 · ExternalCitation · doi-reference

Gene therapy for neovascular age-related macular degeneration by subretinal delivery of RGX-314: a phase 1/2a dose-escalation study

10.1016/s0140-6736(24)00310-6 · ExternalCitation · doi-reference

Understanding the molecular basis and pathogenesis of hereditary optic neuropathies: towards improved diagnosis and management

10.1016/s1474-4422(22)00174-0 · ExternalCitation · doi-reference

A Toll-like receptor recognizes bacterial DNA

10.1038/35047123 · ExternalCitation · doi-reference

Phagocytosis and clearance of apoptotic cells is mediated by MER

10.1038/35075603 · ExternalCitation · doi-reference

Cigarette toxicity triggers Leber's hereditary optic neuropathy by affecting mtDNA copy number, oxidative phosphorylation and ROS detoxification pathways

10.1038/cddis.2015.364 · ExternalCitation · doi-reference

Patient care standards for primary mitochondrial disease: A consensus statement from the Mitochondrial Medicine Society

10.1038/gim.2017.107 · ExternalCitation · doi-reference

Antibody neutralization poses a barrier to intravitreal adeno-associated viral vector gene delivery to non-human primates

10.1038/gt.2014.115 · ExternalCitation · doi-reference

Circulating mitochondrial DAMPs cause inflammatory responses to injury

10.1038/nature08780 · ExternalCitation · doi-reference

The energetics of genome complexity

10.1038/nature09486 · ExternalCitation · doi-reference

A role for mitochondria in NLRP3 inflammasome activation

10.1038/nature09663 · ExternalCitation · doi-reference

Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure

10.1038/nature10992 · ExternalCitation · doi-reference

Mitochondrial DNA stress primes the antiviral innate immune response

10.1038/nature14156 · ExternalCitation · doi-reference

TAM receptors regulate multiple features of microglial physiology

10.1038/nature17630 · ExternalCitation · doi-reference

Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome

10.1038/ni.1980 · ExternalCitation · doi-reference

Microglial phagocytosis of live neurons

10.1038/nrn3710 · ExternalCitation · doi-reference

Molecular mechanisms of mitochondrial DNA release and activation of the cGAS-STING pathway

10.1038/s12276-023-00965-7 · ExternalCitation · doi-reference

Inhibition of cGAS-STING pathway alleviates neuroinflammation-induced retinal ganglion cell death after ischemia/reperfusion injury

10.1038/s41419-023-06140-0 · ExternalCitation · doi-reference

A pathway coordinated by DELE1 relays mitochondrial stress to the cytosol

10.1038/s41586-020-2076-4 · ExternalCitation · doi-reference

Mitochondrial stress is relayed to the cytosol by an OMA1-DELE1-HRI pathway

10.1038/s41586-020-2078-2 · ExternalCitation · doi-reference

Cellular pyrimidine imbalance triggers mitochondrial DNA-dependent innate immunity

10.1038/s42255-021-00385-9 · ExternalCitation · doi-reference

Mitochondrial dysfunction is an important cause of neurological deficits in an inflammatory model of multiple sclerosis

10.1038/srep33249 · ExternalCitation · doi-reference

The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group

10.1056/nejm199312093292403 · ExternalCitation · doi-reference

Multiple sclerosis

10.1056/nejmra1401483 · ExternalCitation · doi-reference

Microglial cGAS-STING signaling underlies glaucoma pathogenesis

10.1073/pnas.2409493121 · ExternalCitation · doi-reference

Optic nerve astrocyte reactivity protects function in experimental glaucoma and other nerve injuries

10.1084/jem.20160412 · ExternalCitation · doi-reference

Worldwide epidemiology of neutralizing antibodies to adeno-associated viruses

10.1086/595830 · ExternalCitation · doi-reference

Prevalence of serum IgG and neutralizing factors against adeno-associated virus (AAV) types 1, 2, 5, 6, 8, and 9 in the healthy population: implications for gene therapy using AAV vectors

10.1089/hum.2009.182 · ExternalCitation · doi-reference

Ocular inflammatory response to intravitreal injection of adeno-associated virus vector: relative contribution of genome and capsid

10.1089/hum.2019.144 · ExternalCitation · doi-reference

HLA-DR15 haplotype and multiple sclerosis: a HuGE review

10.1093/aje/kwk118 · ExternalCitation · doi-reference

Occurrence of a multiple sclerosis-like illness in women who have a Leber's hereditary optic neuropathy mitochondrial DNA mutation

10.1093/brain/115.4.979 · ExternalCitation · doi-reference

Randomized trial of bilateral gene therapy injection for m.11778G>A MT-ND4 Leber optic neuropathy

10.1093/brain/awac421 · ExternalCitation · doi-reference

Leber hereditary optic neuropathy mtDNA mutations disrupt glutamate transport in cybrid cell lines

10.1093/brain/awh258 · ExternalCitation · doi-reference

Gene-environment interactions in Leber hereditary optic neuropathy

10.1093/brain/awp158 · ExternalCitation · doi-reference

A randomized placebo-controlled trial of idebenone in Leber's hereditary optic neuropathy

10.1093/brain/awr170 · ExternalCitation · doi-reference

Circulating mitochondrial DNA and Toll-like receptor 9 are associated with vascular dysfunction in spontaneously hypertensive rats

10.1093/cvr/cvv137 · ExternalCitation · doi-reference

Leber's hereditary optic neuropathy-associated ND6 14484T > C mutation caused pleiotropic effects on the complex I, RNA homeostasis, apoptosis and mitophagy

10.1093/hmg/ddac109 · ExternalCitation · doi-reference

Mitochondrial complex I deficiency leads to inflammation and retinal ganglion cell death in the Ndufs4 mouse

10.1093/hmg/ddv045 · ExternalCitation · doi-reference

Mitophagy activation repairs Leber's hereditary optic neuropathy-associated mitochondrial dysfunction and improves cell survival

10.1093/hmg/ddy354 · ExternalCitation · doi-reference

Leber hereditary optic neuropathy: bridging the translational gap

10.1097/icu.0000000000000410 · ExternalCitation · doi-reference

Defective mitophagy in aged macrophages promotes mitochondrial DNA cytosolic leakage to activate STING signaling during liver sterile inflammation

10.1111/acel.13622 · ExternalCitation · doi-reference

Minocycline: far beyond an antibiotic

10.1111/bph.12139 · ExternalCitation · doi-reference

Review: Mitochondria and disease progression in multiple sclerosis

10.1111/j.1365-2990.2008.00987.x · ExternalCitation · doi-reference

Retinal gene therapy using epiretinal AAV-containing fibrin hydrogel implants

10.1126/sciadv.adv7922 · ExternalCitation · doi-reference

Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA

10.1126/science.1229963 · ExternalCitation · doi-reference

Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway

10.1126/science.1232458 · ExternalCitation · doi-reference

BAK/BAX macropores facilitate mitochondrial herniation and mtDNA efflux during apoptosis

10.1126/science.aao6047 · ExternalCitation · doi-reference

cGAS in action: Expanding roles in immunity and inflammation

10.1126/science.aat8657 · ExternalCitation · doi-reference

VDAC oligomers form mitochondrial pores to release mtDNA fragments and promote lupus-like disease

10.1126/science.aav4011 · ExternalCitation · doi-reference

Engineering adeno-associated viral vectors to evade innate immune and inflammatory responses

10.1126/scitranslmed.abd3438 · ExternalCitation · doi-reference

Cytosolic-DNA-mediated, STING-dependent proinflammatory gene induction necessitates canonical NF-κB activation through TBK1

10.1128/jvi.00037-14 · ExternalCitation · doi-reference

Leber's hereditary optic neuropathy misdiagnosed as optic neuritis and Lyme disease in a patient with multiple sclerosis

10.1136/bcr-2018-227109 · ExternalCitation · doi-reference

Leber hereditary optic neuropathy

10.1136/jmg.39.3.162 · ExternalCitation · doi-reference

MRI in Leber's hereditary optic neuropathy: the relationship to multiple sclerosis

10.1136/jnnp-2014-308186 · ExternalCitation · doi-reference

Mitochondrial DNA release in innate immune signaling

10.1146/annurev-biochem-032620-104401 · ExternalCitation · doi-reference

Nutritional interventions for mitochondrial OXPHOS deficiencies: Mechanisms and model systems

10.1146/annurev-pathol-020117-043644 · ExternalCitation · doi-reference

Triggers and effectors of oxidative stress at blood-brain barrier level: relevance for brain ageing and neurodegeneration

10.1155/2013/297512 · ExternalCitation · doi-reference

Contribution of microglia-mediated neuroinflammation to retinal degenerative diseases

10.1155/2015/673090 · ExternalCitation · doi-reference

Evidence for detrimental cross interactions between reactive oxygen and nitrogen species in Leber's hereditary optic neuropathy cells

10.1155/2016/3187560 · ExternalCitation · doi-reference

Leukocyte diapedesis in vivo induces transient loss of tight junction protein at the blood-retina barrier

10.1167/iovs.04-1333 · ExternalCitation · doi-reference

Oral minocycline for the treatment of diabetic macular edema (DME): results of a phase I/II clinical study

10.1167/iovs.11-9413 · ExternalCitation · doi-reference

Inflammation in viral vector-mediated ocular gene therapy: A review and report from a workshop hosted by the Foundation Fighting Blindness, 9/2020

10.1167/tvst.10.4.3 · ExternalCitation · doi-reference

Overcoming innate immune barriers that impede AAV gene therapy vectors

10.1172/jci143780 · ExternalCitation · doi-reference

The TLR9-MyD88 pathway is critical for adaptive immune responses to adeno-associated virus gene therapy vectors in mice

10.1172/jci37607 · ExternalCitation · doi-reference

CpG-depleted adeno-associated virus vectors evade immune detection

10.1172/jci68205 · ExternalCitation · doi-reference

The genome of self-complementary adeno-associated viral vectors increases Toll-like receptor 9-dependent innate immune responses in the liver

10.1182/blood-2010-10-314518 · ExternalCitation · doi-reference

Plasmacytoid and conventional dendritic cells cooperate in crosspriming AAV capsid-specific CD8+ T cells

10.1182/blood-2016-11-751040 · ExternalCitation · doi-reference

Endothelial mitochondria in the blood-brain barrier

10.1186/s12987-025-00699-w · ExternalCitation · doi-reference

Ketogenic treatment reduces the percentage of a LHON heteroplasmic mutation and increases mtDNA amount of a LHON homoplasmic mutation

10.1186/s13023-019-1128-z · ExternalCitation · doi-reference

Clinical features of MS associated with Leber hereditary optic neuropathy mtDNA mutations

10.1212/01.wnl.0000437308.22603.43 · ExternalCitation · doi-reference

HLA-DRB1*15:01 and the MERTK gene interact to selectively influence the profile of MERTK-expressing monocytes in both health and MS

10.1212/nxi.0000000000200190 · ExternalCitation · doi-reference

Multimodal longitudinal optical imaging reveals optic neuritis preceding retinal pathology in experimental autoimmune encephalomyelitis

10.1212/nxi.0000000000200338 · ExternalCitation · doi-reference

Complement targets newborn retinal ganglion cells for phagocytic elimination by microglia

10.1523/jneurosci.1854-18.2018 · ExternalCitation · doi-reference

ATAD3B is a mitophagy receptor mediating clearance of oxidative stress-induced damaged mitochondrial DNA

10.15252/embj.2020106283 · ExternalCitation · doi-reference

Mitochondrial DNA in inflammation and immunity

10.15252/embr.201949799 · ExternalCitation · doi-reference

FBXL4 deficiency increases mitochondrial removal by autophagy

10.15252/emmm.201911659 · ExternalCitation · doi-reference

A comprehensive review of Leber hereditary optic neuropathy and its association with multiple sclerosis-like phenotypes known as Harding's disease

10.2147/eb.s470184 · ExternalCitation · doi-reference

The blood-retinal barrier in experimental autoimmune uveoretinitis (EAU): a review

10.3109/02713689208999508 · ExternalCitation · doi-reference

Mitochondrial mutations in ethambutol-induced optic neuropathy

10.3389/fcell.2021.754676 · ExternalCitation · doi-reference

Neuroinflammation, microglia and implications for retinal ganglion cell survival and axon regeneration in traumatic optic neuropathy

10.3389/fimmu.2022.860070 · ExternalCitation · doi-reference

Establishment of human Leber's hereditary optic neuropathy model using iPSC-derived retinal organoids

10.3389/fncel.2025.1635775 · ExternalCitation · doi-reference

Leber hereditary optic neuropathy: Review of treatment and management

10.3389/fneur.2021.651639 · ExternalCitation · doi-reference

Leber's hereditary optic neuropathy and multiple sclerosis: overlap between mitochondrial disease and neuroinflammation

10.3389/fneur.2025.1538358 · ExternalCitation · doi-reference

Alterations of oligodendrocyte and myelin energy metabolism in multiple sclerosis

10.3390/ijms241612912 · ExternalCitation · doi-reference

Contribution of mitochondrial dysfunction combined with NLRP3 inflammasome activation in selected neurodegenerative diseases

10.3390/ph14121221 · ExternalCitation · doi-reference

AAV for gene therapy in ocular diseases: Progress and prospects

10.34133/research.0291 · ExternalCitation · doi-reference

cGAS-STING-mediated inflammation and neurodegeneration as a strategy for the treatment of neurodegenerative diseases

10.3724/abbs.2023258 · ExternalCitation · doi-reference

Loss of mitochondrial protease CLPP activates type I IFN responses through the mitochondrial DNA-cGAS-STING signaling axis

10.4049/jimmunol.2001016 · ExternalCitation · doi-reference